COMPANY | Inotrem
KEYSTONE SYMPOSIA Connecting the Scientific Community Keystone Symposia is a 501(c)3 nonprofit directed and supported by the scientific community. Conferences. - ppt download
Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans
5 September 2011
Amazon.com: Jacques Calvet: books, biography, latest update
Roche unterzeichnet Vereinbarung zur Übernahme von Anadys Pharmaceuticals
Leadership Team - Inotrem
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
Lorraine | Economie. Nancy : la start-up Inotrem intègre le French Tech 120
COMPANY | Inotrem
Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics
Jean-Jacques Garaud | Nature Reviews Drug Discovery
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
Jacques Chirac - Wikipedia
Inotrem sparks hope with new phase 2b data
Roche | Jean-Jacques Garaud
Leadership Team - Inotrem
Jean-Jacques Garaud - Co-Founder, Executive Vice-President, Scientific and Medical Affairs @ Inotrem - Crunchbase Person Profile
Board – ENYO Pharma
Jean-Jacques Garaud - Executive Vice-President, Scientific and Medical Affairs - Inotrem | LinkedIn
PDF) sTREM-1 is a specific biomarker of TREM-1 pathway activation
Andera Partners s'entretient avec Jean-Jacques Garaud, CEO d'INOTREM, au portefeuille de notre équipe Andera Life Sciences on Vimeo
